# FDA Inspection 1007059 - Boiron Inc. - February 14, 2017

Source: https://www.keypedia.com/records/fda_inspections/boiron-inc/3f065653-6118-4f80-b305-20852cc18b91
Source feed: FDA_Inspections

> FDA Inspection 1007059 for Boiron Inc. on February 14, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1007059
- Company Name: Boiron Inc.
- Inspection Date: 2017-02-14
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1155509 - 2021-10-25](https://www.keypedia.com/records/fda_inspections/boiron-inc/2188dede-62b5-4eb4-9df0-73f9607ca7a0)
- [FDA Inspection 716890 - 2011-03-18](https://www.keypedia.com/records/fda_inspections/boiron-inc/676e53ae-3723-4ade-bf22-50084bda0a67)

Company: https://www.keypedia.com/companies/boiron-inc/502403cd-f15f-4cf9-8bc2-70e99a8749b4

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c